CBSET is a state-of-the-art translational research institute providing high-quality collaborative GLP studies from proof-of-concept through regulatory filings and IND-enabling studies. CBSET’s mission is to help medical device and biotechnology companies develop unique tools and new methods to promote early diagnosis of, and develop innovative treatments for complex diseases. CBSET provides full preclinical programs, plus specific study design supporting a range of applications in therapeutic and device development, as well as OLAW-assured, AAALAC-accredited animal research facilities. CBSET is based in Lexington (near Boston) and Grafton, MA (USA).

Authors

Ellie Khadir DVM

PhD Scientist & Study Director

Ellie Khadir is an expert in small- and large-animal disease models. At CBSET, she is actively involved in the evaluation of new medical therapies, directing preclinical studies evaluating the safe...

❮ ❯